NEET PG community medicine (psm) questions

The median is the preferred measure of central tendency for skewed distributions because it is not influenced by extreme outlier values, unlike the arithmetic mean, which gets pulled toward the tail of a skewed distribution. In this scenario, a few very high-income households would artificially inflate the mean, making it unrepresentative of the 'typical' household, whereas the median (the middle value when data is ordered) remains a robust and representative measure of central location.

• A. The mean is distorted by extreme high values in skewed data and overestimates the typical value.
• C. Geometric mean is used for data that follows a logarithmic or multiplicative pattern (such as antibody titers), not simply for skewed income data.
• D. The mode only identifies the most frequent value and may not represent the central location well, especially with continuous, widely spread data.

Standard deviation (SD) quantifies the dispersion of individual observations around the mean within a sample and is used to define reference ranges for individuals, such as mean ± 2 SD covering about 95% of values in a normally distributed population. Standard error of mean (SEM), in contrast, measures the precision of the sample mean as an estimate of the true population mean and is used for constructing confidence intervals and hypothesis testing, not for describing individual variability.

• A. SEM reflects the precision of the estimated mean itself, not the spread of individual values, and is used in inferential statistics such as confidence intervals.
• B. Interquartile range describes the spread of the middle 50% of data and is better suited to skewed, non-normal data, not the standard method for a normally distributed reference range.
• C. Coefficient of variation expresses relative variability (SD/mean) and is used to compare variability between datasets with different units or scales, not to set reference ranges directly.

Positive predictive value (PPV) is directly influenced by the prevalence of disease in the tested population, even when sensitivity and specificity remain constant. As prevalence increases, the proportion of true positives among all positive test results increases because there are more diseased individuals in the population, while the number of false positives generated by the fixed specificity remains proportionally smaller. Conversely, in low-prevalence populations, a positive test result is more likely to be a false positive, lowering the PPV, which is why screening programs targeting low-risk groups face more false alarms.

• B. This is incorrect; PPV is dependent on prevalence as well as sensitivity and specificity (via Bayes' theorem).
• C. PPV is not simply equal to sensitivity; it depends on the interplay between sensitivity, specificity, and prevalence.
• D. This is the opposite of the actual relationship; PPV increases, not decreases, with higher prevalence.

One-way ANOVA is the appropriate test when comparing the means of a continuous, normally distributed variable across three or more independent groups, as it tests whether at least one group mean differs significantly from the others while controlling the overall type I error rate. An unpaired t-test is designed to compare only two independent groups and would require multiple pairwise comparisons here, inflating the false-positive risk. Chi-square tests are used for categorical data, not continuous blood pressure values, and paired t-tests are for related or repeated measurements in the same subjects.

• A. Paired t-test is used when comparing two related measurements on the same subjects (e.g., before and after), not three independent groups.
• B. Chi-square test is used to compare proportions or frequencies of categorical variables, not means of a continuous variable.
• D. Unpaired t-test is suited for comparing means between only two independent groups, not three.

A case-control study is the most appropriate and efficient design when studying a rare disease like mesothelioma, because it starts with a small number of already-diagnosed cases and compares their past exposure history with that of controls, requiring far fewer subjects and less time and cost than a cohort study. A cohort study, while useful for studying rare exposures and establishing clear temporality, would require an enormous sample size and long follow-up to accumulate enough mesothelioma cases given its very low incidence, making it impractical here.

• A. A cohort study would require following a very large population for many years to accumulate enough cases of this rare cancer, making it impractical and costly.
• C. A cross-sectional study only provides a snapshot and cannot establish temporal sequence or reliably capture a rare disease at a single point in time.
• D. A randomized controlled trial is unethical and infeasible here since researchers cannot deliberately expose people to a known carcinogen like asbestos.

In a case-control study, the investigator selects subjects based on disease status (cases and controls) and then looks backward at exposure history, so the number of individuals in each disease category is fixed by design. This precludes direct calculation of incidence, and hence relative risk cannot be computed. The odds of exposure among cases versus controls is calculated instead, giving the odds ratio, which approximates relative risk when the disease is rare. Attributable risk and population attributable fraction require knowledge of incidence rates in exposed and unexposed cohorts, which are not available in a case-control design.

• A. Attributable risk needs incidence rates in exposed and unexposed groups, which a case-control study cannot provide.
• B. Relative risk requires incidence data from a cohort followed forward in time, not available here.
• C. Population attributable fraction also depends on incidence data, not odds derived from retrospective sampling.

Recall bias occurs when study participants with the outcome of interest (here, hypertension) remember and report past exposures differently, usually more accurately or more thoroughly, than those without the outcome, because the diagnosis prompts them to reflect on possible causes. This differential recall inflates the measured association between exposure and outcome. Berkson's bias arises from selective hospital-based admission patterns distorting an association, not from differential memory. Lead-time and length-time bias are specific to screening and survival analyses, not relevant to a retrospective exposure history study.

• B. Berkson's bias results from selective hospitalization of cases and controls, not from differences in memory of exposure.
• C. Length-time bias involves screening preferentially detecting slower-growing disease, not applicable to this exposure-recall scenario.
• D. Lead-time bias relates to apparent survival benefit from earlier diagnosis through screening, unrelated to this scenario.

A point source epidemic curve shows a sharp, narrow peak over a short time period corresponding roughly to one incubation period, because all individuals were exposed to the same source at essentially the same time, as seen with the shared wedding meal. A propagated epidemic shows multiple successive waves, each separated by an incubation period, as the agent spreads from person to person. A continuous common source epidemic shows a plateau or prolonged elevated case count because exposure continues over an extended period, such as contamination of a water supply that persists over days or weeks. A mixed pattern would show an initial point-source peak followed by a secondary propagated wave from person-to-person spread, which is not described here since no new cases occurred after the initial peak.

• A. A continuous common source epidemic produces a plateaued curve over a prolonged period, not a single sharp peak.
• B. A propagated epidemic shows successive waves of cases over multiple incubation periods, not a single narrow peak.
• C. A mixed pattern requires a secondary wave of secondary cases from person-to-person spread, which is absent here.

The first step in any outbreak investigation after being notified is to verify the diagnosis by reviewing clinical, laboratory, and epidemiological information and to confirm that the observed increase in cases genuinely represents an outbreak rather than a reporting artifact, seasonal variation, or change in surveillance sensitivity. Only after diagnosis and outbreak existence are confirmed does the investigator proceed to establish a case definition, conduct case finding, and perform descriptive epidemiology. Calculating attack rates and testing hypotheses are later analytical steps that depend on having an accurate case definition and case list already established. Mass empirical treatment without a confirmed diagnosis is inappropriate and could be harmful or wasteful.

• B. Hypothesis testing through analytical studies occurs after descriptive epidemiology, much later in the investigation sequence.
• C. Attack rate calculation requires a case definition and case list, which are established in later steps.
• D. Empirical mass treatment before diagnosis confirmation is inappropriate and is not a step in standard outbreak investigation.

In the early phase of an outbreak of unknown etiology, a working case definition is built from clinical criteria (such as fever with rash), restricted to a specific time period, and a specific place or population, deliberately kept simple and sensitive to capture as many potential cases as possible for further investigation. Requiring laboratory confirmation at this early stage is impractical, since the causative agent is not yet identified and would exclude genuine cases, delaying the response. Using only place of residence or only demographic factors like age and occupation is too narrow and would miss the core clinical and temporal criteria needed to identify a coherent case cluster. As laboratory data become available, the case definition can be refined to include confirmed, probable, and suspect categories.

• A. Laboratory confirmation is not available early in an outbreak of unknown etiology and would be impractical to require upfront.
• B. Place alone does not capture the clinical features or timing needed to define a case appropriately.
• C. Age and occupation alone omit essential clinical and temporal criteria and are insufficient as a standalone case definition.

According to the Universal Immunization Programme, BCG vaccine is given as a single dose of 0.05 mL (not 0.1 mL, which is the dose used beyond one month of age in some other national schedules) by the intradermal route over the left upper arm, at the insertion of the deltoid muscle, ideally at birth or as soon as possible up to one year of age. Intradermal injection produces a characteristic wheal and is essential for the correct local immune response; subcutaneous or intramuscular administration would alter vaccine efficacy and increase risk of abscess formation. The left upper arm is the standardized site in the Indian schedule to maintain consistency in scar documentation across the programme.

• A. The dose for neonates and infants under one month under the Indian UIP is 0.05 mL, not 0.1 mL.
• B. BCG must be given intradermally, not subcutaneously, and the standard UIP site is the left upper arm, not the right.
• C. BCG is never given intramuscularly, and the dose and site described here are both incorrect for this vaccine.

Pentavalent vaccine under UIP combines five antigens: Diphtheria, Pertussis, Tetanus, Hepatitis B, and Haemophilus influenzae type b (Hib). It is given at 6, 10, and 14 weeks of age, followed by a DPT booster at 16-24 months. IPV is given separately as a fractional dose alongside pentavalent at 6 and 14 weeks, not combined within it. Measles is a separate live vaccine given at 9-12 months.

• A. This omits Hepatitis B, which is one of the five components.
• B. This omits Hib and incorrectly adds IPV, which is given as a separate injection, not part of the pentavalent formulation.
• D. Measles is not a component; it is given as a separate vaccine at 9-12 months.

A seizure occurring within 72 hours of a previous DPT dose is a precaution for the whole-cell pertussis component, warranting substitution with DT (diphtheria-tetanus) vaccine instead of DPT for subsequent doses. Pertussis vaccine, especially whole-cell type, is associated with encephalopathy and seizures as adverse events, so switching to DT avoids re-exposure to the pertussis antigen while maintaining diphtheria and tetanus protection. This is a precaution rather than an absolute contraindication to all future immunization. True contraindications to pertussis vaccine include encephalopathy within 7 days of a prior dose not attributable to another cause.

• A. Complete permanent withholding of all vaccines is not warranted; only the pertussis component needs to be avoided.
• B. Giving DPT again risks recurrence of a severe neurological adverse event; antipyretics do not address the underlying precaution.
• C. Dose reduction is not a recognized or effective strategy to prevent AEFI recurrence.

OPV and measles vaccine are heat-sensitive live vaccines that require storage at 2°C to 8°C but should be placed closest to the freezer compartment or freezer plates, as they are more freeze-tolerant and benefit from the coldest zone within that range. In contrast, vaccines like DPT, TT, and Hepatitis B, which are freeze-sensitive, are stored farther from the freezer plates, usually in the middle or lower shelves, to avoid accidental freezing. Freezing damages the aluminum adjuvant in these latter vaccines, reducing immunogenicity, whereas live vaccines like OPV and measles are not adjuvanted and tolerate colder temperatures better.

• A. OPV and measles vaccine are not stored at freezer temperatures within the ILR; that temperature range is for the deep freezer used for ice packs.
• B. The middle shelf is reserved for freeze-sensitive vaccines like DPT and TT, not for OPV and measles.
• D. Vaccines are never stored below 2°C, and storing away from the freezer plate is appropriate for freeze-sensitive vaccines, not OPV and measles.

The Vaccine Vial Monitor is a heat-sensitive label that changes color irreversibly with cumulative heat exposure. When the inner square matches or becomes darker than the surrounding outer circle, it indicates the vaccine has received excessive heat exposure and should not be used, regardless of the stated expiry date. If the inner square is lighter than the outer circle, the vaccine can still be used. VVM status is an endpoint indicator and does not require laboratory confirmation; the vial must be discarded in the field itself.

• A. VVM is a direct visual field indicator meant for immediate decision-making; laboratory testing is unnecessary and impractical in the field.
• B. Vaccines showing VVM endpoint change cannot be salvaged by refreezing; this does not reverse heat damage or restore potency.
• D. This endpoint color change indicates the vaccine is no longer potent and must not be used.

Anaphylaxis occurring shortly after vaccination, caused by a known or expected hypersensitivity response to a vaccine component, is classified as a vaccine product-related reaction, since it results from the inherent properties of the vaccine itself rather than from a manufacturing defect, programmatic error, or psychological response. Vaccine quality defect reactions arise from manufacturing or quality control failures. Programmatic errors result from faults in vaccine handling, preparation, or administration, such as wrong diluent or non-sterile injection. Anxiety-related reactions are vasovagal or stress responses, typically not associated with objective signs like hypotension and wheeze.

• B. There is no indication of a manufacturing or quality control failure such as contamination here.
• C. No programmatic error such as wrong reconstitution, dose, or technique is described.
• D. Anxiety reactions are typically vasovagal (bradycardia, pallor, recovery with rest) and do not cause true anaphylaxis with wheeze and hypotension.

For every reported case of Acute Flaccid Paralysis in a child under 15 years of age, two stool samples must be collected 24 to 48 hours apart, both within 14 days of the onset of paralysis, to maximize the chance of isolating poliovirus before it clears from the gut. The samples are transported in a cold chain (reverse cold chain) to a WHO-accredited laboratory for virus isolation and characterization. Any AFP case is treated as polio until proven otherwise under the surveillance strategy of the Global Polio Eradication Initiative.

• A. The 14-day window is critical because viral shedding diminishes significantly after this period, making 30 days too late.
• B. A single sample is inadequate; two samples are mandatory to increase sensitivity of viral isolation.
• C. Delayed sampling after 60 days would almost certainly miss the period of poliovirus shedding in stool.

WHO classifies acute malnutrition using weight-for-height/length Z-score: moderate acute malnutrition is -3 to <-2 SD, and severe acute malnutrition is less than -3 SD, regardless of the presence of edema. This child's Z-score of -3.5 SD falls below the -3 SD cutoff, qualifying as severe acute malnutrition (wasting) even though he lacks edema, distinguishing it from kwashiorkor which is edematous malnutrition. Severe acute malnutrition can be further subclassified as marasmus (non-edematous, severe wasting) or kwashiorkor/marasmic-kwashiorkor (with edema).

• A. Stunting refers to height-for-age Z-score reflecting chronic malnutrition, not weight-for-height.
• B. Moderate acute malnutrition corresponds to -3 to <-2 SD, not -3.5 SD, which is below this range.
• D. Kwashiorkor requires bilateral pedal edema, which is absent in this child.

In the WHO/IAP management protocol for severe acute malnutrition, the ten steps prioritize treating hypoglycemia and hypothermia first, as these are immediately life-threatening and often coexist due to depleted energy reserves and impaired thermoregulation. The child should be fed F-75 (low-protein, low-lactose therapeutic milk) promptly, which treats and prevents hypoglycemia, and warmed using skin-to-skin contact or warm clothing to correct hypothermia; these two steps are addressed together as the first priority. Intravenous fluids are reserved for shock, since SAM children tolerate IV fluids poorly and are at risk of fluid overload and cardiac failure. Iron supplementation is deferred until the child is in the rehabilitation phase (after at least 2 weeks) because it can worsen oxidative stress and infections during the acute phase.

• A. IV fluids are reserved for shock; this child has no signs of shock, and aggressive IV rehydration risks fluid overload in SAM.
• C. Antibiotics are important in SAM management but are not the first priority over correcting hypoglycemia and hypothermia; they are typically started once the child is stabilized.
• D. Iron is withheld in the initial stabilization phase of SAM as it can promote free radical damage and worsen infections.

The ICMR-NIN RDA (2020) recommends a daily protein intake of 0.83 g/kg body weight for a healthy adult, which accounts for protein quality of a typical mixed Indian diet and replaces the older recommendation of 1 g/kg body weight used in earlier editions. For a 65 kg adult man, this translates to approximately 54 g of protein per day. This value is derived from nitrogen balance studies with an added safety margin for individual variability and is applicable to sedentary to moderately active healthy adults, excluding special states such as pregnancy, lactation, growth, or illness, which require higher intake.

• B. 0.5 g/kg/day is lower than the recommended allowance and would be insufficient to maintain nitrogen balance.
• C. 1.2 g/kg/day exceeds the RDA for a healthy sedentary adult and is closer to requirements for athletes or recovery states.
• D. 1.5 g/kg/day is well above the RDA and corresponds to requirements seen in conditions of significant physiological stress or intense physical training.

The WHO classification of xerophthalmia stages vitamin A deficiency eye findings progressively: XN (night blindness), X1A (conjunctival xerosis, dryness without Bitot's spots), X1B (Bitot's spots, which are triangular, foamy, grayish-white deposits typically on the temporal bulbar conjunctiva composed of keratin debris and Corynebacterium xerosis), X2 (corneal xerosis with haziness), and X3A/X3B (corneal ulceration/keratomalacia). The description of triangular, foamy, grayish conjunctival deposits without corneal involvement is classic for Bitot's spots, staged as X1B. Night blindness often precedes these conjunctival changes and both are reversible with timely vitamin A supplementation.

• B. X2 involves corneal haziness or xerosis, which is not described in this child; the cornea is unaffected.
• C. X3A involves corneal ulceration affecting less than one-third of the corneal surface, which is a more severe stage not present here.
• D. X1A refers to conjunctival xerosis (dullness and dryness) without the characteristic foamy Bitot's spots described here.

WHO/UNICEF/ICCIDD recommend median urinary iodine concentration (UIC) in school-age children as the best indicator for monitoring iodine nutrition status at the population level, because it directly reflects recent dietary iodine intake and responds rapidly to changes in iodine intake, such as after salt iodization programs. A median UIC of 100-199 µg/L indicates adequate iodine intake in a population. Total goiter rate is a useful indicator of chronic iodine deficiency but takes months to years to regress even after correction of iodine intake, making it a poor indicator of current status or short-term programme impact. Cretinism prevalence reflects severe, longstanding deficiency and is not sensitive for monitoring ongoing programme effectiveness.

• A. Cretinism prevalence reflects severe long-standing deficiency and does not sensitively capture current population iodine status or recent programme impact.
• C. Goiter rate reflects chronic past iodine deficiency and regresses slowly, making it a poor indicator of current iodine status after an intervention.
• D. Neonatal TSH screening is used to detect congenital hypothyroidism in individuals, not as the primary population-level monitoring tool for iodine nutrition.

Under the National Iron Plus Initiative, pregnant and lactating women receive one IFA tablet containing 100 mg elemental iron and 500 mcg folic acid daily, starting after the first trimester and continuing through pregnancy and up to 6 months postpartum, for a minimum of 180 tablets. This dose and duration are higher than those used for adolescents or children because of the increased iron demand during pregnancy and lactation. Weekly regimens are used for adolescents (10-19 years), not for lactating women. Pediatric syrup formulations are reserved for children 6-59 months of age.

• A. Pediatric syrup is used for children 6-59 months of age, not adults.
• B. This is the biannual deworming-linked regimen pattern for school children, not the lactating woman protocol.
• D. Weekly IFA with 60 mg iron is the regimen for adolescents, not pregnant/lactating women.

Under NTEP's current diagnostic algorithm, a molecular test such as CBNAAT or truenat (NAAT) is offered as the initial test for all presumptive pulmonary TB patients, since it simultaneously detects M. tuberculosis DNA and rifampicin resistance within hours. This allows upfront detection of drug-resistant TB and faster treatment initiation compared to smear microscopy, which has lower sensitivity and does not detect resistance. Sputum smear microscopy is now reserved for follow-up monitoring of treatment response rather than initial diagnosis. The tuberculin skin test reflects exposure or latent infection and is not used to diagnose active pulmonary TB in adults.

• A. Smear microscopy has lower sensitivity and cannot detect rifampicin resistance, so it is no longer the preferred initial test.
• B. The tuberculin skin test indicates infection/exposure, not active disease, and is not part of the adult pulmonary TB diagnostic algorithm.
• D. Culture takes weeks for results and is not the recommended first test under the current algorithm.

Under NTEP's daily regimen, a new, drug-sensitive pulmonary TB case receives a 2-month intensive phase with four drugs: isoniazid, rifampicin, pyrazinamide, and ethambutol (HRZE), followed by a 4-month continuation phase with isoniazid and rifampicin (HR). This four-drug intensive phase ensures rapid bacillary killing and prevents emergence of resistance. Streptomycin is reserved for retreatment regimens in specific situations, not for standard new cases. Levofloxacin is a second-line drug used only in drug-resistant TB regimens, not in standard first-line treatment.

• A. Levofloxacin is a second-line drug reserved for drug-resistant TB, not standard first-line treatment of a new case.
• C. Streptomycin is not part of the standard regimen for a new case; it was historically used in retreatment regimens.
• D. This three-drug combination omits pyrazinamide, which is a core first-line drug needed in the intensive phase.

Ethambutol causes dose-dependent optic neuritis, presenting with decreased visual acuity and impaired red-green color discrimination, due to its effect on retinal ganglion cells and the optic nerve. Patients on ethambutol should have baseline and periodic visual acuity and color vision testing, and the drug should be stopped immediately if toxicity develops since the damage can become irreversible with continued use. Isoniazid is associated with peripheral neuropathy and hepatotoxicity, not optic neuritis. Rifampicin causes hepatotoxicity and a flu-like reaction, while pyrazinamide is linked to hepatotoxicity and hyperuricemia, neither of which produces this visual syndrome.

• A. Rifampicin is associated with hepatotoxicity and a flu-like syndrome, not visual toxicity.
• B. Pyrazinamide causes hepatotoxicity and hyperuricemia, not optic neuritis.
• C. Isoniazid causes peripheral neuropathy and hepatotoxicity, not optic neuritis.

Under NTEP's standardized treatment outcome definitions, a patient whose treatment was interrupted for two consecutive months or more is classified as "lost to follow-up." This differs from treatment failure, which refers to a patient who remains or becomes sputum/culture positive at or after the fifth month of treatment while still on therapy. "Not evaluated" applies to a patient for whom no treatment outcome is assigned, including those transferred to another unit whose outcome is unknown. Clear, uniform outcome definitions allow accurate cohort analysis and program monitoring across treatment units.

• A. There is no information in the stem suggesting the patient died; the scenario describes non-adherence to follow-up.
• C. Treatment failure refers to persistent bacteriological positivity at or after 5 months of treatment, not interruption of therapy.
• D. "Not evaluated" applies when no outcome could be assigned, such as an unknown outcome after transfer, not simply due to interruption of treatment.

Tuberculosis has been a notifiable disease in India since 2012, making it a legal requirement for every healthcare provider, whether in the public or private sector, to notify every diagnosed TB case to the local health authority. Notification is done through the Nikshay portal, India's web-based TB case management and surveillance system, which captures patient details, diagnosis, and treatment progress to enable program monitoring and patient support. This requirement applies regardless of where the patient is treated or whether treatment is through a government or private facility. Failure to notify is a punishable offense under the relevant government order.

• A. Notification applies to all diagnosed TB cases, not only smear-negative, radiologically suspected cases.
• B. Notification is required at the time of diagnosis, independent of whether the patient is referred to a government center.
• D. Notification is mandatory for all TB cases regardless of whether the patient is managed privately or in the public sector.

NVBDCP recommends ACT (Artesunate + Sulfadoxine-pyrimethamine) for 3 days as first-line treatment for uncomplicated P. falciparum malaria throughout India, combined with a single dose of Primaquine (0.75 mg/kg) as a gametocytocidal agent to reduce transmission. The 14-day Primaquine course is reserved for P. vivax infection to achieve radical cure by eliminating hepatic hypnozoites. Chloroquine is no longer used for falciparum malaria due to widespread resistance across India.

• A. Chloroquine is not used for P. falciparum due to resistance; the 14-day Primaquine schedule is for P. vivax, not P. falciparum.
• B. A 14-day Primaquine course is unnecessary in falciparum malaria since there are no hepatic hypnozoites; only a single gametocytocidal dose is needed.
• D. Chloroquine is ineffective against P. falciparum because of established resistance in India.

Per WHO/NVBDCP dengue classification, the presence of a warning sign (vomiting, in this case at least three episodes would be more severe, but any vomiting plus thrombocytopenia warrants caution) places this patient in the 'dengue with warning signs' category, which mandates hospital admission for close monitoring rather than outpatient management. Warning signs include abdominal pain, persistent vomiting, mucosal bleeding, lethargy, liver enlargement, and rising hematocrit with falling platelets. These patients require admission for monitoring but not necessarily ICU-level intervention unless signs of shock, severe bleeding, or organ impairment (severe dengue) appear. Outpatient discharge is inappropriate once a warning sign is present, as rapid deterioration into the critical phase can occur around defervescence.

• A. ICU-level fluid resuscitation is reserved for severe dengue with shock, organ failure, or severe bleeding, none of which are present here.
• C. Antibiotics have no role in dengue, which is a viral infection; management is supportive with fluid and hematologic monitoring.
• D. Discharge is unsafe once a warning sign (vomiting) is present; the critical phase can develop rapidly.

Culex quinquefasciatus is the principal vector of lymphatic filariasis (Wuchereria bancrofti) in India and characteristically breeds in polluted, stagnant water rich in organic matter, such as blocked drains, cesspools, soakage pits, and pit latrines. Anopheles species breed in clean, slow-moving or stagnant freshwater and transmit malaria, while Aedes aegypti breeds in clean water collections in and around households (coolers, tires, flower pots) and transmits dengue and chikungunya. Recognizing the vector-habitat relationship is essential for targeted larval source management in NVBDCP vector control strategy.

• A. Anopheles culicifacies breeds in clean stagnant water and is a rural malaria vector, not associated with filariasis or polluted water.
• C. Aedes aegypti breeds in clean water in domestic containers and transmits dengue/chikungunya, not filariasis.
• D. Anopheles stephensi is the urban malaria vector breeding in clean water collections like overhead tanks and cisterns, not polluted drains.

The National Kala-azar Elimination Programme recommends single-dose Liposomal Amphotericin B (10 mg/kg IV) as the first-line treatment for visceral leishmaniasis in India, owing to its high cure rate, short duration, and reduced toxicity compared to older agents. The vector is the female Phlebotomus argentipes sandfly, which breeds in cracks of mud walls, cattle sheds, and organic debris in rural endemic areas of Bihar, Jharkhand, and West Bengal. Sodium stibogluconate was previously used but is no longer first-line due to widespread antimonial resistance in the Indian subcontinent. Miltefosine is used as an oral alternative but is not the programmatic first choice due to teratogenicity and compliance concerns.

• B. Sodium stibogluconate is no longer first-line due to high rates of antimonial resistance in the Indian subcontinent.
• C. Miltefosine is an oral second-line/alternative option, not the programmatic first-line drug, which is Liposomal Amphotericin B.
• D. Culex mosquitoes transmit filariasis and Japanese encephalitis, not kala-azar, which is transmitted by sandflies.

The Indian Mass Drug Administration programme for lymphatic filariasis elimination uses annual single-dose Diethylcarbamazine citrate (DEC) plus Albendazole, given to the entire eligible population in endemic districts regardless of infection status, since microfilaria carriers are often asymptomatic and community-wide coverage is needed to interrupt transmission. The triple-drug regimen (Ivermectin + DEC + Albendazole, IDA) is being phased in for select districts per WHO recommendation but is not the traditional nationwide default where contraindications do not apply. DEC is contraindicated in areas co-endemic with onchocerciasis because of severe reactions, but this is not relevant in India, which has no onchocerciasis.

• A. Ivermectin plus Albendazole (without DEC) is the regimen used in areas co-endemic with onchocerciasis, which does not occur in India.
• C. MDA targets the entire eligible population, not only microfilaria-positive individuals, to achieve community-level transmission interruption.
• D. DEC alone, without Albendazole, and twice-yearly dosing is not the standard MDA protocol used in India.

Indoor residual spraying (IRS) is most appropriate here because mud-and-thatch walls retain insecticide well for prolonged residual action, and the strategy does not depend on individual behavioral compliance each night, unlike bed nets, which are undermined by the reported poor usage due to heat discomfort. IRS targets the resting behavior of endophilic, endophagic Anopheles vectors, killing mosquitoes that rest on treated indoor surfaces after feeding. Larviciding is labor-intensive and best suited to areas with limited, identifiable breeding sites rather than being a primary household-level measure, and space spraying provides only short-term knockdown without residual effect, making it unsuitable as the mainstay strategy.

• A. Space spraying (fogging) gives only transient adulticidal effect without residual action and is used for outbreak control, not sustained vector control.
• B. Larviciding requires identifiable, limited breeding sites and is not the primary residual control method for household-level transmission in this scenario.
• C. Nets are undermined by the stated poor compliance due to heat, making this measure unreliable in this specific setting.

Under IDSP/National Polio Surveillance Project case definitions, any child under 15 years presenting with acute flaccid paralysis (AFP) is a reportable 'suspected case' requiring immediate notification, since AFP surveillance is a sensitive indicator for poliovirus circulation even after India's polio-free certification. Two stool specimens must be collected 24-48 hours apart, both within 14 days of paralysis onset, and transported in a cold chain to a WHO-accredited laboratory for virus isolation. Reporting must occur immediately upon clinical suspicion, not after laboratory confirmation or a period of observation, since delayed sample collection reduces the chance of viral isolation and delays outbreak response.

• A. Reporting must happen immediately upon clinical suspicion, not delayed until laboratory confirmation, which would compromise outbreak response.
• B. Observation before reporting defeats the purpose of AFP surveillance, which depends on immediate case reporting and prompt specimen collection.
• C. A single stool sample and the 60-day window are incorrect; two samples 24-48 hours apart within 14 days of onset are required for adequate surveillance sensitivity.

A patient with more than 5 skin lesions and a positive slit-skin smear is classified as multibacillary (MB) leprosy. MB leprosy is treated with triple-drug MDT: Rifampicin and Clofazimine given monthly (supervised), plus daily Dapsone and Clofazimine, for a duration of 12 months. Skin smear positivity, regardless of lesion count, automatically places a case in the multibacillary category requiring the longer, three-drug regimen. Paucibacillary cases (≤5 lesions, smear negative) receive only Rifampicin and Dapsone for 6 months.

• A. This two-drug regimen for 6 months is the paucibacillary schedule, not appropriate for a smear-positive, multi-lesion case.
• B. Dapsone monotherapy is obsolete and leads to drug resistance; it is not part of current WHO/NLEP protocols.
• C. Ofloxacin-based regimens are alternatives used in dapsone hypersensitivity or special situations, not the standard MB regimen.

The priority in an ongoing cholera outbreak is to reduce case fatality through rapid case management: oral rehydration salts for mild-moderate dehydration and intravenous fluids for severe dehydration, combined with disinfection of water sources (chlorination) to interrupt transmission. Oral cholera vaccine has a slow onset of protective immunity (requires two doses, weeks apart) and is used as a complementary preventive measure in high-risk areas, not as the immediate outbreak response. Mass chemoprophylaxis is not recommended as it does not prevent spread and promotes antibiotic resistance. Quarantine is not effective for cholera, which spreads through contaminated water and food, not casual contact.

• A. Cholera is waterborne, not spread by casual contact, so quarantine is not an effective or recommended control measure.
• B. Mass chemoprophylaxis is not recommended by WHO for cholera outbreaks due to risk of resistance and lack of proven benefit.
• C. Vaccination takes weeks to confer immunity and is not the immediate priority during an active outbreak with ongoing deaths.

The window period for HIV is the interval between infection and the appearance of detectable antibodies, typically lasting 2 to 6 weeks and up to 3 months with standard antibody-based assays. Testing too early, as at 10 days, can give a false-negative result even if infection has occurred. The correct approach is to counsel the patient about the window period and advise repeat testing after an adequate interval, generally 6 weeks to 3 months. The NACO testing strategy for diagnosis in asymptomatic low-risk individuals uses three different antigen/antibody-based rapid test kits in series (not simultaneously as a single panel) only once the window period has passed and only to confirm, not substitute for, waiting out the window period.

• A. Unprotected intercourse with a sex worker is a definite risk exposure and warrants testing and counseling, not reassurance without testing.
• B. A single test performed within the window period cannot reliably exclude infection.
• C. The NACO strategy uses sequential testing with three different kits for confirmation, but this does not bypass the need to wait out the window period before testing.

Current NACO guidelines follow the WHO 'test and treat' approach: every pregnant or breastfeeding woman diagnosed with HIV should be started on lifelong triple-drug antiretroviral therapy (ART) as soon as possible after diagnosis, irrespective of CD4 count or clinical stage. This Option B+ strategy maximizes maternal health benefit and minimizes the risk of mother-to-child transmission throughout pregnancy, delivery, and breastfeeding. Early initiation suppresses viral load well before delivery, which is the key determinant of transmission risk. CD4-based deferral, single-dose Nevirapine, and time-limited zidovudine monotherapy are outdated strategies no longer recommended.

• A. Time-limited zidovudine monotherapy was an older regimen; lifelong triple-drug ART is now recommended for all HIV-positive pregnant women.
• C. Single-dose Nevirapine alone is an older, less effective regimen with high risk of resistance and is not current practice.
• D. CD4-based deferral is an outdated strategy; current guidelines recommend immediate ART regardless of CD4 count.

Under the National NCD Programme, population-based screening for common NCDs (hypertension, diabetes, and common cancers) is delivered through a decentralized approach where ASHAs conduct house-to-house visits using a Community-Based Assessment Checklist to identify individuals with risk factors or symptoms. Those screened positive are referred to the sub-center or Primary Health Centre, where the Multi-Purpose Worker or Medical Officer confirms the diagnosis using standard criteria and blood glucose/blood pressure measurement. This ASHA-led first-contact screening maximizes population coverage, especially in rural areas, before clinical confirmation at higher levels.

• A. The staff nurse at the NCD clinic manages confirmed cases at a higher facility level, not the initial community-based screening.
• C. The District Programme Officer has an administrative/managerial role and is not involved in individual-level screening.
• D. The Medical Officer confirms diagnosis after referral; initial population screening is done by the ASHA at the community level.

Under India's National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Disease and Stroke, population-based screening for the three common cancers (cervix, breast, and oral cavity) is recommended for asymptomatic women aged 30 years and above, repeated every 5 years if the initial screen is normal. Visual inspection with acetic acid (VIA) is the preferred low-cost, field-applicable screening method for cervical cancer in resource-limited settings, along with clinical breast examination and oral visual inspection for high-risk habits such as tobacco use. Pap smear and mammography, while sensitive, require greater infrastructure and are not the primary screening modality recommended at the population level in the national program.

• A. HPV DNA testing alone omits screening for breast and oral cancers, which are also covered under the program for this age group.
• B. Pap smear and mammography are resource-intensive and not the first-line population-based screening tools recommended under the national program; annual screening is also not the recommended interval.
• C. Breast cancer screening alone ignores the recommended simultaneous screening for cervical and oral cancers in this age group.

Maternal mortality ratio (MMR) is defined as the number of maternal deaths per 100,000 live births in a given period, calculated as (number of maternal deaths / number of live births) × 100,000. Here, (72 / 24,000) × 100,000 = 300 per 100,000 live births. Stillbirths are excluded from the denominator since MMR uses live births only, distinguishing it from the maternal mortality rate, which uses total population or women of reproductive age as the denominator. This indicator reflects the risk of maternal death per pregnancy or birth and is a key indicator for monitoring progress toward Sustainable Development Goal targets for maternal health.

• A. This value results from an incorrect calculation; the correct ratio using live births as the denominator is 300 per 100,000, not 30.
• B. Maternal mortality ratio is expressed per live births, not per total population; this denominator is used for crude death rate calculations, not MMR.
• D. MMR uses live births alone as the denominator, not total births including stillbirths.

JSSK was launched in 2011 to remove out-of-pocket expenses for pregnant women delivering in public health institutions. It entitles every pregnant woman to free and cashless delivery, including free drugs and consumables, free diagnostics, free diet (up to 3 days for normal delivery, 7 days for cesarean), free blood if required, and free transport from home to institution, between facilities in case of referral, and drop back home. This is distinct from the JSY cash incentive scheme, which only provides a fixed payment and does not cover service costs.

• A. This describes JSY cash assistance alone, not the JSSK entitlement package, which covers actual service costs.
• C. JSSK covers diagnostics and diet routinely, not only when complications occur.
• D. JSSK entitlements include diet and transport as standard components, not left to the family.

A blood pressure of 140/90 mmHg or higher with proteinuria after 20 weeks of gestation meets criteria for pre-eclampsia, which is a high-risk pregnancy condition requiring prompt referral to a facility equipped for maternal and fetal monitoring, antihypertensive therapy, and management of possible complications such as eclampsia or growth restriction. Sub-centers and even many PHCs lack the infrastructure for close monitoring and emergency obstetric care needed for such cases. Early identification and referral under India's antenatal care guidelines is a key strategy to reduce maternal mortality from hypertensive disorders of pregnancy. Delaying referral risks progression to severe pre-eclampsia or eclampsia.

• A. Home bed rest without facility-based monitoring delays necessary evaluation and risks progression to eclampsia.
• B. A sub-center is not equipped to manage hypertensive disorders of pregnancy; this requires referral to a higher facility.
• C. Reassurance and a 4-week follow-up ignore the diagnostic criteria for pre-eclampsia, a high-risk condition needing timely referral.

Infant mortality rate (IMR) measures deaths under 1 year per 1000 live births, neonatal mortality rate (NMR) measures deaths under 28 days per 1000 live births, and under-5 mortality rate (U5MR) measures deaths under 5 years per 1000 live births; by definition NMR ≤ IMR ≤ U5MR. Here IMR (32) accounts for the large majority of U5MR (38), showing most under-5 deaths occur in infancy, and NMR (24) accounts for most of the IMR (32), showing most infant deaths occur in the neonatal period. This pattern reflects the typical epidemiological transition in developing countries where neonatal causes (prematurity, birth asphyxia, sepsis) dominate child mortality as post-neonatal and child mortality decline with improved immunization and nutrition. Tracking the proportion of neonatal deaths within infant deaths helps direct interventions toward newborn care.

• B. U5MR is not simply the sum of IMR and NMR; it is a separate rate capturing all deaths under 5 years, and NMR is already included within IMR.
• C. NMR is always less than or equal to IMR by definition since the neonatal period is a subset of infancy; no error exists here as NMR (24) is less than IMR (32).
• D. The numbers show the opposite: infant deaths (32) make up the bulk of under-5 deaths (38), not deaths after infancy.

Under the Indian Public Health Standards (IPHS), a Primary Health Centre in plain areas serves a population of 30,000, while in hilly, tribal, or difficult terrain the norm is 20,000. A sub-center, the first point of contact, serves 5,000 in plain areas and 3,000 in difficult terrain. A Community Health Centre (CHC), which functions as a referral unit for 4 PHCs, serves 1,20,000 in plain areas and 80,000 in difficult terrain. These norms form the basis for the three-tier rural health infrastructure under the National Health Mission.

• B. 5,000 is the population norm for a sub-center in plain areas, not a PHC.
• C. 1,20,000 is the CHC population norm for plain areas, not a PHC.
• D. 80,000 is the CHC population norm for difficult/hilly terrain, not a PHC.

Primary prevention aims to prevent the onset of disease in healthy individuals by reducing exposure to risk factors or causative agents, such as specific protection measures like iodized salt, immunization, or micronutrient supplementation. Universal salt iodization provides the body with adequate iodine before deficiency develops, fitting the definition of specific protection under primary prevention. Primordial prevention would instead target the underlying social, economic, or environmental conditions (such as general dietary patterns or poverty) that create the risk of iodine deficiency in the first place, rather than directly supplying iodine. Secondary and tertiary prevention apply only after disease (such as clinical goiter or hypothyroidism) has already occurred, through early detection or disability limitation, which does not match this universal, pre-disease intervention.

• A. Primordial prevention addresses root socioeconomic or environmental determinants of risk, not direct specific protection measures like iodized salt.
• B. Secondary prevention involves early detection and treatment of disease that has already begun, not prevention before onset.
• D. Tertiary prevention involves limiting disability or rehabilitation after disease has caused damage, not a pre-disease measure.

Health and Wellness Centres (HWCs) under Ayushman Bharat deliver an expanded range of services known as Comprehensive Primary Health Care, which includes 12 packages: care in pregnancy and childbirth, neonatal and infant health, childhood and adolescent health, family planning, management of communicable diseases, screening and management of non-communicable diseases (hypertension, diabetes, common cancers), basic oral and ENT care, care for mental health, elderly and palliative care, basic ophthalmic care, emergency services, and provision of essential drugs and diagnostics. These centres, upgraded from sub-centers and PHCs, are the first contact point and focus on prevention, screening, and management at the community level. Tertiary interventions like chemotherapy administration, cardiac surgery follow-up, or dialysis require specialized hospital-based care, not primary-level HWCs.

• A. Dialysis requires specialized nephrology infrastructure and is not part of the HWC comprehensive primary care package.
• C. Bypass surgery follow-up requires specialized cardiac care facilities, beyond the scope of primary health care at HWCs.
• D. Chemotherapy administration is a tertiary cancer care service provided at specialized oncology centers, not at primary-level HWCs.

Breakpoint chlorination describes the phenomenon where added chlorine first reacts with ammonia and organic compounds to form combined chlorine (chloramines), causing residual chlorine to rise; as dosing continues, these chloramines are oxidized and destroyed, causing residual chlorine to fall to a minimum, the breakpoint. Beyond this breakpoint, further chlorine addition produces free available chlorine, which is the most effective and rapidly acting disinfectant form, giving a true measure of disinfecting power. Chlorine demand refers to the total chlorine consumed by reducing substances in water before any residual remains, a related but distinct concept describing the quantity needed to satisfy oxidizable material. Water treatment practice aims to dose chlorine beyond the breakpoint to ensure an adequate free residual (typically 0.5 mg/L after 30 minutes contact) for effective disinfection, not merely to destroy all pathogens instantly or to stay below an arbitrary dose limit.

• A. There is no single maximum permissible dose defined by this curve; the breakpoint instead marks the dose beyond which free residual chlorine becomes available.
• B. The breakpoint is a chemical phenomenon on the dose-residual curve; it does not certify complete destruction of all pathogens.
• C. Chlorine demand is the amount consumed by oxidizable substances before a residual appears, a related but different concept from the breakpoint dip.

Byssinosis occurs in workers exposed to cotton, flax or hemp dust, particularly in the carding and blow room areas where raw fibre is processed and endotoxin-laden dust is highest. The hallmark is 'Monday morning chest tightness', symptoms that are worst after a period away from exposure (weekend) and improve with continued exposure during the week, reflecting tolerance development. Chest X-ray is typically normal or shows no significant fibrosis, unlike silicosis or asbestosis. Diagnosis is clinical, based on the characteristic temporal pattern of symptoms linked to occupational cotton dust exposure.

• A. Farmer's lung is a hypersensitivity pneumonitis from mouldy hay exposure, causing acute fever and dyspnoea hours after exposure, not a cotton dust-related pattern.
• B. Asbestosis follows asbestos exposure (shipbuilding, insulation work) and causes lower-zone pulmonary fibrosis with pleural plaques, not cyclical Monday symptoms.
• D. Silicosis results from silica dust exposure (mining, sandblasting, stone cutting) and causes progressive fibrosis with upper-zone nodular opacities, not a Monday-morning symptom pattern.